Telemonitoring of Type 2 Diabetes Mellitus in Italy.
Source: Dario, C., et al. 2017 - Pubmed ID: 27379995
Setting: Italy,
Study design:
RCT
Follow up: 12 months
Patient group:
Sample size:
Total: 299(243)
IG: 208 (166)
CG: 91 (77)
Inclusion criteria:
- Diabetes type2
- HbA1c > 53mmol/mol (7.0%)
Type of technology:
Home monitoring
- Glucometer
- Home care portal (Gateway for data transmission)
Intervention:
Intervention: Patients monitored and transmitted data to an eHealth Center. Clinicians could access the Home Care portal any time and were informed when anomalies were detected, to take appropriate action.
Duration: NA
Add on: NA
Control group: Usual care
Clinical effect:
- HbA1c →
- Physical Component Summary →
- Mental Component Summary ↓ (worse)
Patient safety: NA
Patient experiences/
Staff experiences:
Patient experiences: NA
Staff experiences: NA
Investment:
Equipment/Materials
- Blood glucose
Running:
Staff resources
- Staff for monitoring clinical data
Organization: NA
Health care utilization:
- Outpatient visits to diabetologists ↓
- Planned hospitalization ↓
- Emergency department visits →
- Bed days for hospitalized patients →